Faeth TherapeuticsFTH
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 45 institutions reported holding Faeth Therapeutics Inc. (FTH) in their 13F filings, up 15 from Q1 2026. 22 opened new positions and 7 sold out. The largest holders were Montanova Capital, LLC ($50.5M), Avoro Capital Advisors LLC ($36.1M) and Baker Bros. Advisors LP ($32.2M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Faeth Therapeutics Inc.
- CUSIP
- 81728A207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 22 | $160.0M |
| Exits | 7 | $14.8M |
All 13F filers, Q1 2026 → Q2 2026: 12,400,290 shares bought and 483,173 shares sold, net +11,917,117 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 45 holders
| Montanova Capital, LLC | 1.06% | Add +5747.1% | 2,020,103 | $50.5M |
| Avoro Capital Advisors LLC | 0.32% | New | 1,444,039 | $36.1M |
| Baker Bros. Advisors LP | 0.16% | New | 1,286,411 | $32.2M |
| Balyasny Asset Management L.P. | 0.05% | Add +6331.3% | 1,042,198 | $26.1M |
| Vivo Capital, LLC | 1.65% | No change | 722,020 | $18.1M |
| Fairmount Funds Management LLC | 1.19% | New | 722,020 | $18.1M |
| Logos Global Management LP | 0.78% | Add +2306.7% | 722,020 | $18.1M |
| Ra Capital Management, L.P. | 0.16% | New | 722,020 | $18.1M |
| Caligan Partners LP | 0.76% | Add +399.6% | 629,467 | $15.7M |
| B Group, Inc. | 8.66% | New | 610,169 | $15.3M |
| Trails Edge Capital Partners, LP | 2.05% | Add +312.3% | 515,335 | $12.9M |
| Franklin Resources Inc. | 0.00% | Add +270.4% | 494,516 | $12.4M |
| Octagon Capital Advisors LP | 0.83% | New | 361,010 | $9.0M |
| ADAR1 Capital Management, LLC | 0.43% | New | 361,010 | $9.0M |
| Cormorant Asset Management, LP | 0.39% | Add +235.8% | 1,028,242 | $7.7M |
| Marshall Wace, LLP | 0.00% | Add +214.2% | 206,508 | $5.2M |
| Boxer Capital Management, LLC | 0.34% | New | 180,505 | $4.5M |
| Patient Square Capital LP | 0.68% | New | 175,050 | $4.4M |
| Affinity Asset Advisors, LLC | 0.18% | New | 144,404 | $3.6M |
| Alyeska Investment Group, L.P. | 0.01% | New | 144,404 | $3.6M |
| Boothbay Fund Management, LLC | 0.07% | Add +411.6% | 133,643 | $3.3M |
| AWM Investment Company, Inc. | 0.24% | New | 111,343 | $2.8M |
| Richmond Investment Services, LLC | 0.63% | New | 79,731 | $2.0M |
| Ikarian Capital, LLC | 0.14% | Add +457.2% | 35,386 | $885K |
| UBS Group AG | 0.00% | Add +375.6% | 21,541 | $539K |
| Renaissance Technologies | 0.00% | Reduce -36.3% | 20,416 | $510K |
| Jane Street Group, LLC | 0.00% | Add +126.8% | 20,117 | $503K |
| Morgan Stanley | 0.00% | Add +97.0% | 17,329 | $433K |
| Catalio Capital Management, LP | 0.07% | No change | 14,718 | $368K |
| Geode Capital Management, LLC | 0.00% | Add +53.8% | 14,616 | $365K |
| Superstring Capital Management LP | 0.22% | New | 14,175 | $354K |
| Barclays PLC | 0.00% | New | 12,412 | $310K |
| Citadel Advisors | 0.00% | New | 12,296 | $307K |
| Vanguard Capital Management LLC | 0.00% | Add +30.5% | 10,115 | $253K |
| XTX Topco Ltd | 0.00% | New | 9,608 | $240K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 6,307 | $158K |
| China Universal Asset Management Co., Ltd. | 0.01% | New | 3,600 | $90K |
| BlackRock, Inc. | 0.00% | New | 3,402 | $85K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -56.5% | 650 | $16K |
| Royal Bank of Canada | 0.00% | New | 509 | $13K |
| BNP Paribas Financial Markets | 0.00% | Add +1155.6% | 113 | $3K |
| JPMorgan Chase & Co. | 0.00% | Add +25.0% | 40 | $929 |
| Quarry LP | 0.00% | New | 32 | $800 |
| Physician Wealth Advisors, Inc. | 0.00% | New | 28 | $700 |
| SBI Securities Co., Ltd. | 0.00% | No change | 4 | $100 |
"% of holder's portfolio" is FTH's weight in each manager's 13F, not the share of Faeth Therapeutics Inc. the manager owns.